Literature DB >> 9647549

Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.

H O Critchley1, H Wang, R W Kelly, A E Gebbie, A F Glasier.   

Abstract

This study has examined endometrial tissue in 14 normal women prior to insertion of a levonorgestrel-releasing intrauterine system (LNG-IUS) and thereafter longitudinally for up to 12 months post-insertion. The specific endpoints examined by immunohistochemistry were progesterone receptor (PR) subtypes A + B, oestrogen receptor (ER) and prostaglandin dehydrogenase (PGDH). Two antiprogesterone receptor antibodies, one specific to PR(B) subtype and the other to PR subtype A + B, were employed to examine the localization of both PR isoforms. The activity of PGDH, a progesterone dependent enzyme, was also measured. ER and PR(A+B) and PR subtype B were significantly down-regulated in glands and stroma in the presence of continuous intrauterine LNG delivery. There was an apparent increase in PR(A) immunoreactivity in endometrial glands between 6 and 12 months post-insertion. Consistent with down-regulation of both isoforms of PR was reduced glandular PGDH immunostaining following LNG-IUS insertion, and PGDH activity (as measured by metabolism of excess substrate in vitro). Furthermore, PGDH activity, known to be localized in the glands, significantly increased (P < 0.05) at 12 months post-insertion, coinciding with the observed increase in glandular PR(A+B) immunoreactivity at this time. Since the LNG-IUS suppresses the PR(B) so strongly, PR(A) is likely to be the subtype that mediates long term LNG action in the endometrium. PR(B) is the more suppressed of the two subtypes, and only PR(A) rises along with PGDH activity. Alterations to normal endometrial morphology and function, e.g. perturbation of normal sex steroid receptor expression, following exposure to high concentrations of local LNG, may play a role in the aetiology of bleeding disorders associated with the LNG-IUS. Further elucidation of local uterine mediators involved in the mechanism of bleeding problems is required.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Methods--side effects; Developed Countries; Diseases; Endocrine System; Endometrial Effects; Endometrium; Europe; Family Planning; Genitalia; Genitalia, Female; Hormone Receptors; Iud, Hormone Releasing--side effects; Iud--side effects; Levonorgestrel--pharmacodynamics; Membrane Proteins; Menstruation Disorders--etiology; Northern Europe; Physiology; Prostaglandins; Research Methodology; Research Report; United Kingdom; Urogenital System; Uterus

Mesh:

Substances:

Year:  1998        PMID: 9647549     DOI: 10.1093/humrep/13.5.1210

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  13 in total

Review 1.  The endometrial lymphatic vasculature: function and dysfunction.

Authors:  Jane E Girling; Peter A W Rogers
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514

2.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding.

Authors:  Charles J Lockwood; Graciela Krikun; Martha Hickey; S Joseph Huang; Frederick Schatz
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

4.  Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair.

Authors:  Jacqueline A Maybin; Nikhil Hirani; Henry N Jabbour; Hilary O D Critchley
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding.

Authors:  Jacqueline F Donoghue; C Jay McGavigan; Fiona L Lederman; Leonie M Cann; Lulu Fu; Eva Dimitriadis; Jane E Girling; Peter A W Rogers
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

6.  The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F₂α during human endometrial repair.

Authors:  Jacqueline A Maybin; Nikhil Hirani; Pamela Brown; Henry N Jabbour; Hilary O D Critchley
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

7.  Intercellular adhesion molecule-1 expression in human endometrium: implications for long term progestin only contraception.

Authors:  Frederick Schatz; Graciela Krikun; Rebecca N Baergen; Hilary O D Critchley; Edward Kuczynski; Charles J Lockwood
Journal:  Reprod Biol Endocrinol       Date:  2006-01-30       Impact factor: 5.211

Review 8.  A critical period of progesterone withdrawal precedes menstruation in macaques.

Authors:  Ov D Slayden; Robert M Brenner
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

9.  Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium.

Authors:  M-L Alvarez Gonzalez; C Galant; F Frankenne; M Nisolle; S Labied; J-M Foidart; E Marbaix; A Béliard
Journal:  Hum Reprod       Date:  2008-12-17       Impact factor: 6.918

10.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.